Mode
Text Size
Log in / Sign up

Immersive virtual reality rehabilitation improved dynamic balance, motor function, and quality of life in Parkinson's disease patients.

Immersive virtual reality rehabilitation improved dynamic balance, motor function, and quality of li…
Photo by Cht Gsml / Unsplash
Key Takeaway
Consider immersive virtual reality for dynamic balance and motor function in Parkinson's disease, noting limitations in static balance data.

This systematic review and meta-analysis evaluated the effectiveness of fully immersive virtual reality or immersive virtual environment rehabilitation compared to conventional treatment in individuals with Parkinson's disease. Data were pooled from 13 studies included in the analysis. The primary outcomes assessed included dynamic balance measured by the Timed Up and Go Test, motor function assessed via the Unified Parkinson's Disease Rating Scale, and quality of life measured by the Parkinson's Disease Questionnaire-39. Secondary outcomes included static balance, the Tinetti scale, falls efficacy, and cognitive performance.

The analysis found that fully immersive virtual reality rehabilitation resulted in significantly improved dynamic balance, motor function, and quality of life compared to conventional treatment. Conversely, the review reported no significant changes for static balance, the Tinetti scale, the Falls Efficacy Scale-International, or cognitive performance. Specific effect sizes, absolute numbers, and p-values were not reported in the source data.

Safety and tolerability data were not reported for adverse events, serious adverse events, discontinuations, or general tolerability within the included studies. A key limitation identified was high heterogeneity for quality of life outcomes, with an I2 greater than 50%. The authors emphasize the need for future randomized controlled trials with larger samples and extended follow-up to address these gaps.

The practice relevance suggests that rehabilitation integrating fully immersive virtual reality may be more effective than conventional treatment for specific functional domains in Parkinson's disease. However, clinicians should interpret these findings cautiously given the heterogeneity and lack of detailed statistical reporting. The evidence does not support claims of benefit for static balance or falls efficacy based on this review.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
OBJECTIVE: This systematic review and meta-analysis evaluated the effectiveness of fully immersive virtual reality and fully immersive virtual environment in improving balance, motor function, cognitive performance, and quality of life in individuals with Parkinson's disease, compared with conventional treatment. DESIGN: PubMed, Cochrane Library, and Web of Science were searched up to April 2025. Of the 983 studies screened, 13 studies met the inclusion criteria, following the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. Individuals with Parkinson's disease receiving fully immersive virtual reality/immersive virtual environment rehabilitation were included compared with conventional treatment. The meta-analysis only included randomized controlled trials and was conducted using RevMan 5.4.1 with a random-effects model and 95% confidence intervals. RESULTS: Fully immersive virtual reality/immersive virtual environment significantly improved dynamic balance Timed Up and Go Test(s) test and motor function (Unified Parkinson's Disease Rating Scale) with low heterogeneity, and quality of life (Parkinson's Disease Questionnaire-39) with high heterogeneity ( I2 > 50%) compared with conventional treatment. No significant changes were found for the static balance (Berg Balance Scale), Tinetti scale, and Falls Efficacy Scale-International. CONCLUSIONS: Rehabilitation integrating fully immersive virtual reality/immersive virtual environment showed greater effectiveness than conventional treatment in improving dynamic balance, motor function, and quality of life in individuals with Parkinson's disease. Future randomized controlled trials with larger samples and extended follow-up are necessary to strengthen the evidence.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.